Salvador-Carulla, L, Bertelli, M.
'Mental retardation' or 'intellectual disability': time for a conceptual change. Psychopathology
2008; 41: 10–6.
Li, MM, Andersson, HC. Clinical application of microarray-based molecular cytogenetics: an emerging new era of genomic medicine. J Pediatrics
2009; 105: 311–7.
Taylor, MRG, Jirikowic, J, Wells, C, Springer, M, McGavran, L, Lunt, B, et al. High prevalence of array comparative genomic hybridization abnormalities in adults with unexplained intellectual disability. Genet Med
2010; 12: 32–8.
Statham, H, Ponder, M, Richards, M, Hallowell, N, Raymond, FL. A family perspective of the value of a diagnosis for intellectual disability: experiences from a genetic research study. Br J Learn Disabil
2011; 39: 46–56.
Berg, K, Arron, K, Burbridge, C, Moss, J, Oliver, C.
Carer-reported contemporary health problems in people with severe and profound intellectual disability and genetic syndromes. J Policy Practice Intellect Disabil
2007; 4: 120–8.
Ropers, HH. Genetics of intellectual disability. Curr Opin Genet Develop
2008; 18: 241–50.
Stankiewicz, P, Beaudet, AL. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay and idiopathic mental retardation. Curr Opin Genet Develop
2007; 17: 182–92.
Ward, L, Howarth, J, Rodgers, J.
Difference and choice: exploring prenatal testing and the use of genetic information with people with learning difficulties. Br J Learn Disabil
2002; 30: 50–5.
Costain, G, Chow, EWC, Ray, PN, Bassett, AS. Caregiver and adult patient perspectives on the importance of a diagnosis of 22q11.2 deletion syndrome. J Intellect Disabil Res
2012; 56: 641–51.
Holland, A, Clare, I.
The human genome project: considerations for people with intellectual disabilities. J Intellect Disabil Res
2003; 47: 515–25.
Skinner, D, Sparkman, KL, Bailey, DB. Screening for Fragile X Syndrome: parent attitudes and perspectives. Genet Med
2003; 5: 378–84.
Royal College of Physicians, Royal College of Pathologists, British Society for Human Genetics. Consent and Confidentiality in Genetic Practice: Guidance on Genetic Testing and Sharing Genetic Information. Report of the Joint Committee on Medical Genetics. RCP, RCPath, BSHG, 2005.
Bailey, DB, Beskow, LM, Davis, AM, Skinner, D.
Changing perspectives on the benefits of newborn screening. Ment Retard Dev Disabil Res Rev
2006; 12: 270–9.
Graham, SM, Selikowitz, M.
Chromosome testing in children with developmental delay in whom the aetiology is not evident clinically. J Paediatr Child Health
1993; 29: 360–2.
Moeschler, JB, Shevell, M.
Clinical genetic evaluation of the child with mental retardation or developmental delays. Pediatrics
2006; 117: 2304–16.
Jacquemont, S, Curie, A, des Portes, V, Torrioli, MG, Berry-Kravis, E, Hagerman, RJ, et al. Epigenetic modification of the FMR1 gene in Fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med
2011; 3: 64ra1.